Heidi Health
Rivalling OpenEvidence and DoxGPT, Heidi’s latest offering, Heidi Evidence, sets itself apart by allowing clinicians to upload their own sources and documents.
Clinician innovators across the region see the next phase of healthcare AI focusing on trust and responsible adoption after a year of rapid experimentation.
The funding boosts the Australia-based company's valuation to $465 million and brings its total raise to almost $100 million.
Also, Heidi Health has announced a new partnership for its New Zealand expansion.
Upcoming features include pre-chart summary creation.
Heidi Health recently raised $6.5 million in Series A funding for its nationwide expansion.